
AstraZeneca’s potential exit raises alarm for UK markets – The Irish Times
AstraZeneca chief executive Pascal Soriot isn’t confirming or denying reports that the UK’s largest listed company is considering moving its primary stock market listing from London to New York. Yet recent remarks reveal where the company’s future may lie. At AstraZeneca’s half-year results press conference, Soriot gushed about the US, “the country in our industry…